These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 1453204)

  • 41. Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma.
    DuBois SG; Groshen S; Park JR; Haas-Kogan DA; Yang X; Geier E; Chen E; Giacomini K; Weiss B; Cohn SL; Granger MM; Yanik GA; Hawkins R; Courtier J; Jackson H; Goodarzian F; Shimada H; Czarnecki S; Tsao-Wei D; Villablanca JG; Marachelian A; Matthay KK
    Clin Cancer Res; 2015 Jun; 21(12):2715-21. PubMed ID: 25695691
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targeted radiotherapy with submyeloablative doses of 131I-MIBG is effective for disease palliation in highly refractory neuroblastoma.
    Kang TI; Brophy P; Hickeson M; Heyman S; Evans AE; Charron M; Maris JM
    J Pediatr Hematol Oncol; 2003 Oct; 25(10):769-73. PubMed ID: 14528098
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preoperative [131I]metaiodobenzylguanidine therapy of neuroblastoma at diagnosis ("MIBG de novo").
    Hoefnagel CA; de Kraker J; Voûte PA; Valdés Olmos RA
    J Nucl Biol Med (1991); 1991; 35(4):248-51. PubMed ID: 1823828
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reaching the target dose with one single
    Fiz F; Cirone A; Righi S; Massollo M; Amoroso L; Bottoni G; Conte M; Gambaro M; Massone F; Orengo S; Bruzzone GS; Sorrentino S; Garaventa A; Piccardo A
    Pediatr Blood Cancer; 2024 Mar; 71(3):e30806. PubMed ID: 38082548
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Therapeutic effect of m-[131I]- and m-[125I]iodobenzylguanidine on neuroblastoma multicellular tumor spheroids of different sizes.
    Weber W; Weber J; Senekowitsch-Schmidtke R
    Cancer Res; 1996 Dec; 56(23):5428-34. PubMed ID: 8968097
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Optimum combination of targeted 131I and total body irradiation for treatment of disseminated cancer.
    Amin AE; Wheldon TE; O'Donoghue JA; Gaze MN; Barrett A
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):713-21. PubMed ID: 7790258
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Survival of patients with neuroblastoma treated with 125-I MIBG.
    Sisson JC; Shapiro B; Hutchinson RJ; Shulkin BL; Zempel S
    Am J Clin Oncol; 1996 Apr; 19(2):144-8. PubMed ID: 8610638
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pretreatment with [131I] metaiodobenzylguanidine and surgical resection of advanced neuroblastoma.
    van Hasselt EJ; Heij HA; de Kraker J; Vos A; Voûte PA
    Eur J Pediatr Surg; 1996 Jun; 6(3):155-8. PubMed ID: 8817208
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 131I-metaiodobenzylguanidine in the treatment of neuroblastoma at diagnosis.
    Mastrangelo R; Troncone L; Lasorella A; Riccardi R; Montemaggi P; Rufini V
    Am J Pediatr Hematol Oncol; 1989; 11(1):28-31. PubMed ID: 2785352
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The biodistribution and pharmacokinetics of meta-iodobenzylguanidine in childhood neuroblastoma.
    Lashford LS; Moyes J; Ott R; Fielding S; Babich J; Mellors S; Gordon I; Evans K; Kemshead JT
    Eur J Nucl Med; 1988; 13(11):574-7. PubMed ID: 3350034
    [TBL] [Abstract][Full Text] [Related]  

  • 51. First line targeted radiotherapy, a new concept in the treatment of advanced stage neuroblastoma.
    De Kraker J; Hoefnagel CA; Caron H; Valdés Olmos RA; Zsiros J; Heij HA; Voûte PA
    Eur J Cancer; 1995; 31A(4):600-2. PubMed ID: 7576977
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of the dicentric chromosome assay as a biodosimetry tool for more personalized medicine in a case of a high risk neuroblastoma
    Chimeno JM; Sebastià N; Torres-Espallardo I; Balaguer J; Candela-Juan C; Loaiza JL; Adria M; Ibanez-Rosello B; Cañete A; Martí-Bonmatí L; Montoro A
    Int J Radiat Biol; 2019 Mar; 95(3):314-320. PubMed ID: 30496023
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The current status of radioiodinated metaiodobenzylguanidine therapy of neuro-endocrine tumors.
    Shapiro B; Sisson JC; Shulkin BL; Gross MD; Zempel S
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):55-7. PubMed ID: 9002750
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy.
    Mastrangelo S; Tornesello A; Diociaiuti L; Pession A; Prete A; Rufini V; Troncone L; Mastrangelo R
    Br J Cancer; 2001 Feb; 84(4):460-4. PubMed ID: 11207038
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neuroblastoma: dose-related sensitivity of MIBG scanning in detection.
    Parisi MT; Matthay KK; Huberty JP; Hattner RS
    Radiology; 1992 Aug; 184(2):463-7. PubMed ID: 1620849
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Experience with palliative [131I]metaiodobenzylguanidine therapy in advanced neuroblastoma.
    Castellani MR; Rottoli L; Maffioli L; Massimino M; Gasparini M; Buraggi GL
    J Nucl Biol Med (1991); 1991; 35(4):241-3. PubMed ID: 1726677
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of neuroblastoma with 131I-metaiodobenzylguanidine.
    Troncone L; Riccardi R; Montemaggi P; Rufini V; Lasorella A; Mastrangelo R
    Med Pediatr Oncol; 1987; 15(4):220-3. PubMed ID: 3657712
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnosis and treatment of neuroblastoma using 131I-meta-iodobenzylguanidine.
    Edeling CJ; Büchler Frederiksen P; Kamper J; Jeppesen P
    Nuklearmedizin; 1986 Oct; 25(5):172-5. PubMed ID: 3797256
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The use of [131I]metaiodobenzylguanidine in the treatment of neuroblastoma after conventional therapy.
    Troncone L; Rufini V; Riccardi R; Lasorella A; Mastrangelo R
    J Nucl Biol Med (1991); 1991; 35(4):232-6. PubMed ID: 1823825
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of advanced neuroblastoma with I-131 meta-iodobenzylguanidine.
    Garaventa A; Guerra P; Arrighini A; Bertolazzi L; Bestagno M; De Bernardi B; Lanino E; Villavecchia GP; Claudiani F
    Cancer; 1991 Feb; 67(4):922-8. PubMed ID: 1991264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.